Biomarkers in sickle cell disease

British Journal of Haematology

Volumn 156, Issue 4, 2012, Pages 433-445

  Rees, David C ^a   Gibson, John S ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Biomarkers; Coagulation; Haemolysis; Inflammation; Sickle cell disease

Indexed keywords

APOLIPOPROTEIN A1; ARGINASE; ARGININE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD36 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIN 1; HAPTOGLOBIN; HEMOGLOBIN; HEMOGLOBIN F; HEMOGLOBIN S; LACTATE DEHYDROGENASE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRITE; ORNITHINE; PHOSPHATIDYLETHALONAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PLACENTAL GROWTH FACTOR; SECRETORY PHOSPHOLIPASE A2; TRIACYLGLYCEROL; TROPONIN I; UNCLASSIFIED DRUG; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 4;

ALPHA THALASSEMIA; ANEMIA; BLOOD VISCOSITY; BONE DISEASE; CYTOMETRY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE FILTERABILITY; ERYTHROCYTE LIFESPAN; ERYTHROCYTE SEDIMENTATION RATE; HEART DISEASE; HEMOLYSIS; HUMAN; HYPERCOAGULABILITY; HYPOXEMIA; INFLAMMATION; KIDNEY DYSFUNCTION; LEUKOCYTE ADHERENCE; MEAN CORPUSCULAR HEMOGLOBIN; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN POLYMERIZATION; REPERFUSION INJURY; RETICULOCYTE COUNT; REVIEW; SICKLE CELL ANEMIA; SPLEEN DISEASE; VASCULAR DISEASE;

ANEMIA, SICKLE CELL; ANOXIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; DEHYDRATION; ERYTHROCYTES; HEMOGLOBIN, SICKLE; HEMOLYSIS; HUMANS; INFLAMMATION; NITRIC OXIDE; OSMOTIC FRAGILITY; OXIDATIVE STRESS; PROTEIN MULTIMERIZATION; REPERFUSION INJURY; THROMBOPHILIA;

EID: 84856279998     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08961.x     Document Type: Review

References (107)

1. Adams, R.J., McKie, V.C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F.T., Bonds, D.R. & Brambilla, D. (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. The New England Journal of Medicine, 339, 5-11.
2. Adewoye, A.H., Klings, E.S., Farber, H.W., Palaima, E., Bausero, M.A., McMahon, L., Odhiambo, A., Surinder, S., Yoder, M., Steinberg, M.H. & Asea, A. (2005) Sickle cell vaso-occlusive crisis induces the release of circulating serum heat shock protein-70. American Journal of Hematology, 78, 240-242.
3. Asakura, T., Mattiello, J.A., Obata, K., Asakura, K., Reilly, M.P., Tomassini, N., Schwartz, E. & Ohene-Frempong, K. (1994) Partially oxygenated sickled cells: sickle-shaped red cells found in circulating blood of patients with sickle cell disease. Proceedings of the National Academy of Sciences of the United States of America, 91, 12589-12593.
4. Asakura, T., Asakura, K., Obata, K., Mattiello, J. & Ballas, S.K. (2005) Blood samples collected under venous oxygen pressure from patients with sickle cell disease contain a significant number of a new type of reversibly sickled cells: constancy of the percentage of sickled cells in individual patients during steady state. American Journal of Hematology, 80, 249-256.
5. Asare, K., Gee, B.E., Stiles, J.K., Wilson, N.O., Driss, A., Quarshie, A., Adams, R.J., Kutlar, A. & Hibbert, J.M. (2010) Plasma interleukin-1beta concentration is associated with stroke in sickle cell disease. Cytokine, 49, 39-44.
6. Ataga, K.I., Moore, C.G., Hillery, C.A., Jones, S., Whinna, H.C., Strayhorn, D., Sohier, C., Hinderliter, A., Parise, L.V. & Orringer, E.P. (2008) Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. Haematologica, 93, 20-26.
7. Athanassiou, G., Moutzouri, A., Kourakli, A. & Zoumbos, N. (2006) Effect of hydroxyurea on the deformability of the red blood cell membrane in patients with sickle cell anemia. Clinical Hemorheology and Microcirculation, 35, 291-295.
8. Ballas, S.K. & Smith, E.D. (1992) Red blood cell changes during the evolution of the sickle cell painful crisis. Blood, 79, 2154-2163.
9. Barabino, G.A., Platt, M.O. & Kaul, D.K. (2010) Sickle cell biomechanics. Annual Review of Biomedical Engineering, 12, 345-367.
10. Bargoma, E.M., Mitsuyoshi, J.K., Larkin, S.K., Styles, L.A., Kuypers, F.A. & Test, S.T. (2005) Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vasoocclusive crisis or acute chest syndrome. Blood, 105, 3384-3385.
11. van Beem, R.T., Nur, E., Zwaginga, J.J., Landburg, P.P., van Beers, E.J., Duits, A.J., Brandjes, D.P., Lommerse, I., de Boer, H.C., van der Schoot, C.E., Schnog, J.J. & Biemond, B.J. (2009) Elevated endothelial progenitor cells during painful sickle cell crisis. Experimental Hematology, 37, 1054-1059.
12. Bergmann, S., Zheng, D., Barredo, J., Abboud, M.R. & Jaffa, A.A. (2006) Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 28, 147-153.
13. Billett, H.H., Kim, K., Fabry, M.E. & Nagel, R.L. (1986) The percentage of dense red cells does not predict incidence of sickle cell painful crisis. Blood, 68, 301-303.
14. Biomarkers Definitions Working Group. (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics, 69, 89-95.
15. Brandao, M.M., Fontes, A., Barjas-Castro, M.L., Barbosa, L.C., Costa, F.F., Cesar, C.L. & Saad, S.T. (2003) Optical tweezers for measuring red blood cell elasticity: application to the study of drug response in sickle cell disease. European Journal of Haematology, 70, 207-211.
16. Brittain, J.E. & Parise, L.V. (2007) Cytokines and plasma factors in sickle cell disease. Current Opinion in Hematology, 14, 438-443.
17. Brownell, A., Lowson, S. & Brozovic, M. (1986) Serum ferritin concentration in sickle cell crisis. Journal of Clinical Pathology, 39, 253-255.
18. Bunn, H.F. (1997) Pathogenesis and treatment of sickle cell disease. New England Journal of Medicine, 337, 762-769.
19. Cajado, C., Cerqueira, B.A., Couto, F.D., Moura-Neto, J.P., Vilas-Boas, W., Dorea, M.J., Lyra, I.M., Barbosa, C.G., Reis, M.G. & Goncalves, M.S. (2011) TNF-alpha and IL-8: serum levels and gene polymorphisms (-308G>A and -251A>T) are associated with classical biomarkers and medical history in children with sickle cell anemia. Cytokine, 56, 312-317.
20. Chapelon, E., Garabedian, M., Brousse, V., Souberbielle, J.C., Bresson, J.L. & de Montalembert, M. (2009) Osteopenia and vitamin D deficiency in children with sickle cell disease. European Journal of Haematology, 83, 572-578.
21. Charache, S. (1997) Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Seminars in Hematology, 34, 15-21.
22. Cho, C.S., Kato, G.J., Yang, S.H., Bae, S.W., Lee, J.S., Gladwin, M.T. & Rhee, S.G. (2010) Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia. Antioxidants & Redox Signaling, 13, 1-11.
23. Conran, N., Fattori, A., Saad, S.T. & Costa, F.F. (2004) Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea. American Journal of Hematology, 76, 343-347.
24. De Franceschi, L., Bachir, D., Galacteros, F., Tchernia, G., Cynober, T., Alper, S., Platt, O., Beuzard, Y. & Brugnara, C. (1997) Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. The Journal of Clinical Investigation, 100, 1847-1852.
25. De Franceschi, L., Cappellini, M.D. & Olivieri, O. (2011) Thrombosis and sickle cell disease. Seminars in Thrombosis and Hemostasis, 37, 226-236.
26. Diatta, A., Toure-Fall, A.O., Sarr, N.G., Diallo, F., Diagne, I., Lopez-Sall, P., Wone, I., Vassauft, A., Sall, N.D., Thiam, D. & Toure, M. (2004) [Prevalence of antiphospholipid antibodies in patients with sickle cell disease]. Annales de Biologie Clinique, 62, 291-294.
27. Dworkis, D.A., Klings, E.S., Solovieff, N., Li, G., Milton, J.N., Hartley, S.W., Melista, E., Parente, J., Sebastiani, P., Steinberg, M.H. & Baldwin, C.T. (2011) Severe sickle cell anemia is associated with increased plasma levels of TNF-R1 and VCAM-1. American Journal of Hematology, 86, 220-223.
28. Eastman, R.D. (1984) Clinical Haematology. John Wright & Sons Ltd, Bristol.
29. Emeribe, A.O., Udoh, A.E., Etukudoh, M.H., Okany, C.C., Kehinde, M., Catty, D. & Raykundalia, C. (2000) Hypofibronectinaemia and severity of sickle cell anaemia in Nigeria. British Journal of Haematology, 111, 1194-1197.
30. Fabry, M.E., Mears, J.G., Patel, P., Schaefer-Rego, K., Carmichael, L.D., Martinez, G. & Nagel, R.L. (1984) Dense cells in sickle cell anemia: the effects of gene interaction. Blood, 64, 1042-1046.
31. Field, J.J., Strunk, R.C., Knight-Perry, J.E., Blinder, M.A., Townsend, R.R. & DeBaun, M.R. (2009) Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease. American Journal of Hematology, 84, 231-233.
32. Gibson, J.S. & Ellory, J.C. (2002) Membrane transport in sickle cell disease. Blood Cells, Molecules, and Diseases, 28, 303-314.
33. Gladwin, M.T., Sachdev, V., Jison, M.L., Shizukuda, Y., Plehn, J.F., Minter, K., Brown, B., Coles, W.A., Nichols, J.S., Ernst, I., Hunter, L.A., Blackwelder, W.C., Schechter, A.N., Rodgers, G.P., Castro, O. & Ognibene, F.P. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350, 886-895.
34. Graido-Gonzalez, E., Doherty, J.C., Bergreen, E.W., Organ, G., Telfer, M. & McMillen, M.A. (1998) Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood, 92, 2551-2555.
35. Haynes, Jr, J., Obiako, B., Hester, R.B., Baliga, B.S. & Stevens, T. (2008) Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium. American Journal of Physiology. Heart and Circulatory Physiology, 294, H379-H385.
36. Hebbel, R.P. (2011) Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine. American Journal of Hematology, 86, 123-154.
37. Hebbel, R.P., Boogaerts, M.A., Eaton, J.W. & Steinberg, M.H. (1980) Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. The New England Journal of Medicine, 302, 992-995.
38. Hoover, R., Rubin, R., Wise, G. & Warren, R. (1979) Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures. Blood, 54, 872-876.
39. Hoppe, C., Kuypers, F., Larkin, S., Hagar, W., Vichinsky, E. & Styles, L. (2011) A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. British Journal of Haematology, 153, 655-663.
40. Inwald, D.P., Kirkham, F.J., Peters, M.J., Lane, R., Wade, A., Evans, J.P. & Klein, N.J. (2000) Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. British Journal of Haematology, 111, 474-481.
41. Kato, G.J., Martyr, S., Blackwelder, W.C., Nichols, J.S., Coles, W.A., Hunter, L.A., Brennan, M.L., Hazen, S.L. & Gladwin, M.T. (2005) Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. British Journal of Haematology, 130, 943-953.
42. Kato, G.J., McGowan, V., Machado, R.F., Little, J.A., Taylor, J.t., Morris, C.R., Nichols, J.S., Wang, X., Poljakovic, M., Morris, Jr, S.M. & Gladwin, M.T. (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood, 107, 2279-2285.
43. Kato, G.J., Gladwin, M.T. & Steinberg, M.H. (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Reviews, 21, 37-47.
44. Kato, G.J., Wang, Z., Machado, R.F., Blackwelder, W.C., Taylor, J.G.t. & Hazen, S.L. (2009) Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. British Journal of Haematology, 145, 506-513.
45. Kaul, D.K., Finnegan, E. & Barabino, G.A. (2009) Sickle red cell-endothelium interactions. Microcirculation, 16, 97-111.
46. Kearney, S.L., Nemeth, E., Neufeld, E.J., Thapa, D., Ganz, T., Weinstein, D.A. & Cunningham, M.J. (2007) Urinary hepcidin in congenital chronic anemias. Pediatric Blood & Cancer, 48, 57-63.
47. Krishnan, S., Setty, Y., Betal, S.G., Vijender, V., Rao, K., Dampier, C. & Stuart, M. (2010) Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises. British Journal of Haematology, 148, 797-804.
48. Landburg, P.P., Nur, E., Maria, N., Brandjes, D.P., Biemond, B.J., Schnog, J.B. & Duits, A.J. (2009) Elevated circulating stromal-derived factor-1 levels in sickle cell disease. Acta Haematologica, 122, 64-69.
49. Landburg, P.P., Teerlink, T., Biemond, B.J., Brandjes, D.P., Muskiet, F.A., Duits, A.J. & Schnog, J.B. (2010) Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype. Blood Cells, Molecules & Diseases, 44, 229-232.
50. Lapoumeroulie, C., Benkerrou, M., Odievre, M.H., Ducrocq, R., Brun, M. & Elion, J. (2005) Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea. Haematologica, 90, 401-403.
51. Lard, L.R., Mul, F.P., de Haas, M., Roos, D. & Duits, A.J. (1999) Neutrophil activation in sickle cell disease. Journal of Leukocyte Biology, 66, 411-415.
52. Lee, K., Gane, P., Roudot-Thoraval, F., Godeau, B., Bachir, D., Bernaudin, F., Cartron, J.P., Galacteros, F. & Bierling, P. (2001) The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia. Blood, 98, 966-971.
53. Lee, S.P., Ataga, K.I., Orringer, E.P., Phillips, D.R. & Parise, L.V. (2006) Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1626-1631.
54. Machado, R.F., Anthi, A., Steinberg, M.H., Bonds, D., Sachdev, V., Kato, G.J., Taveira-DaSilva, A.M., Ballas, S.K., Blackwelder, W., Xu, X., Hunter, L., Barton, B., Waclawiw, M., Castro, O. & Gladwin, M.T. (2006) N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA: the Journal of the American Medical Association, 296, 310-318.
55. Mekontso Dessap, A., Leon, R., Habibi, A., Nzouakou, R., Roudot-Thoraval, F., Adnot, S., Godeau, B., Galacteros, F., Brun-Buisson, C., Brochard, L. & Maitre, B. (2008) Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. American Journal of Respiratory and Critical Care Medicine, 177, 646-653.
56. Miller, S.T., Sleeper, L.A., Pegelow, C.H., Enos, L.E., Wang, W.C., Weiner, S.J., Wethers, D.L., Smith, J. & Kinney, T.R. (2000) Prediction of adverse outcomes in children with sickle cell disease. New England Journal of Medicine, 342, 83-89.
57. Minniti, C.P., Sable, C., Campbell, A., Rana, S., Ensing, G., Dham, N., Onyekwere, O., Nouraie, M., Kato, G.J., Gladwin, M.T., Castro, O.L. & Gordeuk, V.R. (2009) Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica, 94, 340-347.
58. Mock, D.M., Matthews, N.I., Zhu, S., Strauss, R.G., Schmidt, R.L., Nalbant, D., Cress, G.A. & Widness, J.A. (2011) Red blood cell (RBC) survival determined in humans using RBCs labeled at multiple biotin densities. Transfusion, 51, 1047-1057.
59. Mohan, J.S., Lip, P.L., Blann, A.D., Bareford, D. & Lip, G.Y. (2005) The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment. The British Journal of Ophthalmology, 89, 815-819.
60. Mohandas, N. & Gallagher, P.G. (2008) Red cell membrane: past, present, and future. Blood, 112, 3939-3948.
61. Moller, H.J., Nielsen, M.J., Bartram, J., Dick, M.C., Height, S.E., Moestrup, S.K. & Rees, D.C. (2011) Soluble CD163 levels in children with sickle cell disease. British Journal of Haematology, 153, 105-110.
62. de Montalembert, M., Aggoun, Y., Niakate, A., Szezepanski, I. & Bonnet, D. (2007) Endothelial-dependent vasodilation is impaired in children with sickle cell disease. Haematologica, 92, 1709-1710.
63. Morris, C.R., Kuypers, F.A., Larkin, S., Sweeters, N., Simon, J., Vichinsky, E.P. & Styles, L.A. (2000) Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. British Journal of Haematology, 111, 498-500.
64. Morris, C.R., Kato, G.J., Poljakovic, M., Wang, X., Blackwelder, W.C., Sachdev, V., Hazen, S.L., Vichinsky, E.P., Morris, Jr, S.M. & Gladwin, M.T. (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA: the Journal of the American Medical Association, 294, 81-90.
65. Morris, C.R., Suh, J.H., Hagar, W., Larkin, S., Bland, D.A., Steinberg, M.H., Vichinsky, E.P., Shigenaga, M., Ames, B., Kuypers, F.A. & Klings, E.S. (2008) Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood, 111, 402-410.
66. Nebor, D., Durpes, M.C., Mougenel, D., Mukisi-Mukaza, M., Elion, J., Hardy-Dessources, M.D. & Romana, M. (2010) Association between Duffy antigen receptor for chemokines expression and levels of inflammation markers in sickle cell anemia patients. Clinical Immunology, 136, 116-122.
67. Niu, X., Nouraie, M., Campbell, A., Rana, S., Minniti, C.P., Sable, C., Darbari, D., Dham, N., Reading, N.S., Prchal, J.T., Kato, G.J., Gladwin, M.T., Castro, O.L. & Gordeuk, V.R. (2009) Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease. PLoS One, 4, e7956.
68. Nur, E., Mairuhu, W., Biemond, B.J., van Zanten, A.P., Schnog, J.J., Brandjes, D.P. & Otten, H.M. (2010) Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis. American Journal of Hematology, 85, 902-904.
69. Nur, E., van Beers, E.J., Martina, S., Cuccovillo, I., Otten, H.M., Schnog, J.J., Meijers, J.C., Mantovani, A., Brandjes, D.P., Bottazzi, B. & Biemond, B.J. (2011a) Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis. Blood Cells, Molecules & Diseases, 46, 189-194.
70. Nur, E., Biemond, B.J., Otten, H.M., Brandjes, D.P. & Schnog, J.J. (2011b) Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. American Journal of Hematology, 86, 484-489.
71. Odhiambo, A., Perlman, D.H., Huang, H., Costello, C.E., Farber, H.W., Steinberg, M.H., McComb, M.E. & Klings, E.S. (2007) Identification of oxidative post-translational modification of serum albumin in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension of sickle cell anemia. Rapid Communications in Mass Spectrometry: RCM, 21, 2195-2203.
72. O'Driscoll, S., Height, S.E., Dick, M.C. & Rees, D.C. (2008) Serum lactate dehydrogenase activity as a biomarker in children with sickle cell disease. British Journal of Haematology, 140, 206-209.
73. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H. & Gill, F.M. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288-294.
74. Okpala, I., Daniel, Y., Haynes, R., Odoemene, D. & Goldman, J. (2002) Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells. European Journal of Haematology, 69, 135-144.
75. Platt, O.S., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E. & Kinney, T.R. (1991) Pain in sickle cell disease. Rates and risk factors. New England Journal of Medicine, 325, 11-16.
76. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine, 330, 1639-1644.
77. Rees, D.C., Cervi, P., Grimwade, D., O'Driscoll, A., Hamilton, M., Parker, N.E. & Porter, J.B. (1995) The metabolites of nitric oxide in sickle-cell disease. British Journal of Haematology, 91, 834-837.
78. Rees, D.C., Dick, M.C., Height, S.E., O'Driscoll, S., Pohl, K.R., Goss, D.E. & Deane, C.R. (2008) A simple index using age, hemoglobin, and aspartate transaminase predicts increased intracerebral blood velocity as measured by transcranial Doppler scanning in children with sickle cell anemia. Pediatrics, 121, e1628-e1632.
79. Rees, D.C., Williams, T.N. & Gladwin, M.T. (2010) Sickle-cell disease. Lancet, 376, 2018-2031.
80. Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon, 3rd, R.O., Schechter, A.N. & Gladwin, M.T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 1383-1389.
81. Rodgers, G.P., Noguchi, C.T. & Schechter, A.N. (1985) Irreversibly sickled erythrocytes in sickle cell anemia: a quantitative reappraisal. American Journal of Hematology, 20, 17-23.
82. Rogers, Z.R., Wang, W.C., Luo, Z., Iyer, R.V., Shalaby-Rana, E., Dertinger, S.D., Shulkin, B.L., Miller, J.H., Files, B., Lane, P.A., Thompson, B.W., Miller, S.T. & Ware, R.E. (2011) Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial. Blood, 117, 2614-2617.
83. Scheinman, J.I. (2009) Sickle cell disease and the kidney. Nature Clinical Practice. Nephrology, 5, 78-88.
84. Sherwood, J.B., Goldwasser, E., Chilcote, R., Carmichael, L.D. & Nagel, R.L. (1986) Sickle cell anemia patients have low erythropoietin levels for their degree of anemia. Blood, 67, 46-49.
85. Shet, A.S., Aras, O., Gupta, K., Hass, M.J., Rausch, D.J., Saba, N., Koopmeiners, L., Key, N.S. & Hebbel, R.P. (2003) Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood, 102, 2678-2683.
86. Shimauti, E.L., Silva, D.G., de Almeida, E.A., Zamaro, P.J., Belini Junior, E. & Bonini-Domingos, C.R. (2010) Serum melatonin level and oxidative stress in sickle cell anemia. Blood Cells, Molecules & Diseases, 45, 297-301.
87. Sloma, I., Zilber, M.T., Charron, D., Girot, R., Tamouza, R. & Gelin, C. (2004) Upregulation and atypical expression of the CD1 molecules on monocytes in sickle cell disease. Human Immunology, 65, 1370-1376.
88. Solovey, A., Lin, Y., Browne, P., Choong, S., Wayner, E. & Hebbel, R.P. (1997) Circulating activated endothelial cells in sickle cell anemia. The New England Journal of Medicine, 337, 1584-1590.
89. Stein, P.D., Beemath, A., Meyers, F.A., Skaf, E. & Olson, R.E. (2006) Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. The American Journal of Medicine, 119, 897.e7-11.
90. Steinberg, M.H. (2009) Genetic etiologies for phenotypic diversity in sickle cell anemia. ScientificWorldJournal, 9, 46-67.
91. Strijbos, M.H., Landburg, P.P., Nur, E., Teerlink, T., Leebeek, F.W., Rijneveld, A.W., Biemond, B.J., Sleijfer, S., Gratama, J.W., Duits, A.J. & Schnog, J.J. (2009) Circulating endothelial cells: a potential parameter of organ damage in sickle cell anemia? Blood Cells, Molecules & Diseases, 43, 63-67.
92. Stuart, J. & Johnson, C.S. (1987) Rheology of sickle cell disorders. In: Blood Rheology and Hyperviscoity Syndromes (ed. by G.D.O. Lowe), Vol. 1.3, pp. 747-776. Bailliere Tindall, London.
93. Styles, L.A., Lubin, B., Vichinsky, E., Lawrence, S., Hua, M., Test, S. & Kuypers, F. (1997) Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood, 89, 2554-2559.
94. Styles, L.A., Aarsman, A.J., Vichinsky, E.P. & Kuypers, F.A. (2000) Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood, 96, 3276-3278.
95. Styles, L.A., Abboud, M., Larkin, S., Lo, M. & Kuypers, F.A. (2007) Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. British Journal of Haematology, 136, 343-344.
96. Sundaram, N., Tailor, A., Mendelsohn, L., Wansapura, J., Wang, X., Higashimoto, T., Pauciulo, M.W., Gottliebson, W., Kalra, V.K., Nichols, W.C., Kato, G.J. & Malik, P. (2010) High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension. Blood, 116, 109-112.
97. Sundaram, N., Bennett, M., Wilhelm, J., Kim, M.O., Atweh, G., Devarajan, P. & Malik, P. (2011) Biomarkers for early detection of sickle nephropathy. American Journal of Hematology, 86, 559-566.
98. Symeonidis, A., Kouraklis-Symeonidis, A., Constantinidou, I., Solomou, E., Kougelou, S., Vassilakos, P. & Zoumbos, N. (2006) Increased CA-15.3 levels in the serum of patients with homozygous beta-thalassaemia and sickle cell/beta-thalassaemia. British Journal of Haematology, 133, 692-694.
99. Tharaux, P.L., Hagege, I., Placier, S., Vayssairat, M., Kanfer, A., Girot, R. & Dussaule, J.C. (2005) Urinary endothelin-1 as a marker of renal damage in sickle cell disease. Nephrology, Dialysis, Transplantation, 20, 2408-2413.
100. Turhan, A., Weiss, L.A., Mohandas, N., Coller, B.S. & Frenette, P.S. (2002) Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proceedings of the National Academy of Sciences of the United States of America, 99, 3047-3051.
101. Ulug, P., Vasavda, N., Kumar, R., Keir, L., Awogbade, M., Cunningham, J., Rees, D.C., Menzel, S. & Thein, S.L. (2008) Hydroxyurea therapy lowers circulating DNA levels in sickle cell anemia. American Journal of Hematology, 83, 714-716.
102. Vekilov, P.G. (2007) Sickle-cell haemoglobin polymerization: is it the primary pathogenic event of sickle-cell anaemia? British Journal Haematology, 139, 173-184.
103. Vichinsky, E.P., Neumayr, L.D., Earles, A.N., Williams, R., Lennette, E.T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C. & Manci, E.A. (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine, 342, 1855-1865.
104. Yuditskaya, S., Tumblin, A., Hoehn, G.T., Wang, G., Drake, S.K., Xu, X., Ying, S., Chi, A.H., Remaley, A.T., Shen, R.F., Munson, P.J., Suffredini, A.F. & Kato, G.J. (2009) Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood, 113, 1122-1128.
105. Yuditskaya, S., Suffredini, A.F. & Kato, G.J. (2010) The proteome of sickle cell disease: insights from exploratory proteomic profiling. Expert Review of Proteomics, 7, 833-848.
106. Zhang, Y., Dai, Y., Wen, J., Zhang, W., Grenz, A., Sun, H., Tao, L., Lu, G., Alexander, D.C., Milburn, M.V., Carter-Dawson, L., Lewis, D.E., Eltzschig, H.K., Kellems, R.E., Blackburn, M.R., Juneja, H.S. & Xia, Y. (2011) Detrimental effects of adenosine signaling in sickle cell disease. Nature Medicine, 17, 79-86.
107. Zorca, S., Freeman, L., Hildesheim, M., Allen, D., Remaley, A.T., Taylor, J.G.t. & Kato, G.J. (2010) Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. British Journal of Haematology, 149, 436-445.